article thumbnail

Medicare’s GLP-1 spending is skyrocketing, even without weight loss coverage: KFF

Healthcare Dive

Gross Medicare spending on the pricey drugs rose from $57 million in 2018 to $5.7 billion in 2022, according to a new analysis from the health policy group.

Medicare 304
article thumbnail

CMS Issues Long-Awaited Medicare Advantage RADV Final Rule

Healthcare Law Blog

On January 30, 2023 , the Centers for Medicare & Medicaid Services (“CMS”) released the long-delayed final rule on risk adjustment data validation (“RADV”) audits of Medicare Advantage (“MA”) organizations (the “Final Rule”). One thing that is certain, CMS can expect further challenges to its RADV audit methodology. 3d 1, 18 n.19

Medicare 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CMS’s Final Rule on Medicare Advantage Risk Adjustment Data Validation

Health Law Advisor

On February 1, 2023, the Centers for Medicare & Medicaid Services (CMS) published a final rule outlining its audit methodology and related policies for its Medicare Advantage (MA) Risk Adjustment Data Validation (RADV) program. The final rule codifies long-awaited regulations first proposed by CMS in 2018.

article thumbnail

KFF: Part D spending on Ozempic skyrocketed between 2018 and 2022

Fierce Healthcare

Spending on GLP-1 drugs in Medicare Part D has spiked massively over the past several years, according to a new analysis from KFF.

article thumbnail

Nearly half of physicians using telehealth, up from just 18% in 2018

Healthcare IT News - Telehealth

Physicians are changing the patterns of their practice because of the COVID-19 pandemic, with nearly half of them using telehealth to treat patients, up from just 18% in 2018. The 2018 survey had indicated that telemedicine use among physicians was more prominent among younger doctors. WHY IT MATTERS.

COVID-19 162
article thumbnail

CMS has finalized its remedy for 340B payments, and hospitals are not happy

Fierce Healthcare

The Centers for Medicare & Medicaid Services has dropped the final rule to remedy the invalidated 340B-acquired drug payment policy for calendar years 2018 to 2022. |

Hospitals 118
article thumbnail

Medicare Advantage RADV Audit Final Rule Challenged in Court

Healthcare Law Blog

The Centers for Medicare & Medicaid Services (“CMS”) released the final rule on risk adjustment data validation (“RADV”) audits of Medicare Advantage (“MA”) organizations (the “Final Rule”) on January 30, 2023. As we predicted in February , this Final Rule is now being challenged in court.